Insulet Corp (PODD)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Insulet Corp (PODD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011134
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes OmniPod insulin management system, an insulin infusion system for diabetic patients. OmniPod insulin management system consists of OmniPod, a disposable insulin infusion device and the Personal Diabetes Manager, a handheld wireless device. Its OmniPod is a tubeless insulin pump that has two parts and a fully-automated cannula insertion. The company’s delivery systems business collaborates with several global pharmaceutical and biotechnology companies to adapt the OmniPod technology platform for the delivery of subcutaneous drugs across various therapeutic areas. The company markets its products in the US, Europe, and Asia through direct sales and distribution partners. Insulet is headquartered in Bedford, Massachusetts, the US.

Insulet Corp (PODD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Insulet Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Insulet Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Insulet Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Insulet Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Insulet Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Insulet Corp, Medical Equipment, Deal Details 11
Asset Purchase 11
Insulet Acquires US Manufacturing Facility in Acton, Massachusetts 11
Venture Financing 12
Glooko Raises USD35 Million in Series C Financing 12
Partnerships 14
Insulet Enters into Licensing Agreement with Mode AGC 14
Insulet Extends Licensing Agreement with Abbott Diabetes Care 15
Insulet Amends Licensing Agreement With Abbott Diabetes 16
Insulet Amends Licensing Agreement With Abbott Diabetes Care 17
Ascensia Diabetes Care Enters into Development Agreement with Insulet 18
Insulet Enters into Co-Development Agreement with Eli Lilly 19
Insulet Enters Into Co-Development Agreement With Eli Lilly 20
Insulet Expands Distribution Agreement With Ypsomed Holding 21
Insulet Enters Into Technology Integration Agreement With LifeScan 22
Insulet Enters Into Distribution Agreement With GlaxoSmithKline 23
Equity Offering 24
Insulet Completes Public Offering Of Common Stock For US$98 Million 24
Debt Offering 26
Insulet Prices Private Placement of 1.375% Notes Due 2024 for USD350 Million 26
Insulet Raises Private Placement of Senior Notes for USD345 Million 27
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 28
Insulet Completes Public Offering Of Convertible Senior Notes Due 2016 For US$144 Million 30
Acquisition 31
Liberty Medical Acquires Neighborhood Diabetes from Insulet for USD5 Million 31
Insulet Acquires Neighborhood Diabetes 32
Insulet Corp – Key Competitors 33
Insulet Corp – Key Employees 34
Insulet Corp – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Strategy And Business Planning 36
Sep 28, 2017: Insulet Breaks Ground on New U.S. Manufacturing Facility 36
Financial Announcements 37
Nov 02, 2017: Insulet Reports Third Quarter 2017 Financial Results 37
Aug 03, 2017: Insulet Reports Second Quarter 2017 Financial Results 38
May 08, 2017: Insulet Reports First Quarter 2017 Financial Results 39
Feb 27, 2017: Insulet Reports Fourth Quarter and Full Year 2016 Financial Results 40
Nov 03, 2016: Insulet Reports Third Quarter 2016 Financial Results 42
Aug 03, 2016: Insulet Reports Second Quarter 2016 Financial Results 43
May 03, 2016: Insulet Reaffirms Second Quarter and Full Year 2016 Guidance 44
Apr 28, 2016: Insulet Reports First Quarter 2016 Financial Results 45
Feb 25, 2016: Insulet Reports Fourth Quarter and Full Year 2015 Financial Results 46
Corporate Communications 48
Aug 10, 2017: Insulet Appoints Michael R. Minogue and James C. Mullen to Board of Directors 48
May 30, 2017: Insulet Appoints Bret Christensen as Chief Commercial Officer 49
Oct 19, 2016: Insulet Announces Board and Management Changes 50
Sep 06, 2016: Insulet Announces Executive Appointments 51
Mar 16, 2016: Insulet Names Aiman Abdel-Malek, Ph.D. Senior Vice President of Advanced Technology and Engineering 52
Mar 02, 2016: Insulet Announces Organizational Enhancements 53
Feb 09, 2016: Insulet Appoints David A. Lemoine to Board of Directors 54
Legal and Regulatory 55
Jun 10, 2016: Insulet Partners with Joslin Diabetes Center to Implement a Unique Training Certification for Insulet’s Clinical Team 55
Product News 56
Jul 13, 2016: Insulet Launches New Educational iPad App: Toby’s T1D Tale 56
May 23, 2016: Insulet Launches New Omnipod Podder Community Platform 57
01/19/2016: Insulet Raises Funds for Continued Diabetes Research 58
Other Significant Developments 59
Sep 06, 2016: Insulet to Establish Highly-Automated Manufacturing Operation in the United States 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List of Tables
Insulet Corp, Medical Equipment, Key Facts, 2016 2
Insulet Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Insulet Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Insulet Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Insulet Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Insulet Corp, Deals By Market, 2011 to YTD 2017 9
Insulet Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Insulet Acquires US Manufacturing Facility in Acton, Massachusetts 11
Glooko Raises USD35 Million in Series C Financing 12
Insulet Enters into Licensing Agreement with Mode AGC 14
Insulet Extends Licensing Agreement with Abbott Diabetes Care 15
Insulet Amends Licensing Agreement With Abbott Diabetes 16
Insulet Amends Licensing Agreement With Abbott Diabetes Care 17
Ascensia Diabetes Care Enters into Development Agreement with Insulet 18
Insulet Enters into Co-Development Agreement with Eli Lilly 19
Insulet Enters Into Co-Development Agreement With Eli Lilly 20
Insulet Expands Distribution Agreement With Ypsomed Holding 21
Insulet Enters Into Technology Integration Agreement With LifeScan 22
Insulet Enters Into Distribution Agreement With GlaxoSmithKline 23
Insulet Completes Public Offering Of Common Stock For US$98 Million 24
Insulet Prices Private Placement of 1.375% Notes Due 2024 for USD350 Million 26
Insulet Raises Private Placement of Senior Notes for USD345 Million 27
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 28
Insulet Completes Public Offering Of Convertible Senior Notes Due 2016 For US$144 Million 30
Liberty Medical Acquires Neighborhood Diabetes from Insulet for USD5 Million 31
Insulet Acquires Neighborhood Diabetes 32
Insulet Corp, Key Competitors 33
Insulet Corp, Key Employees 34
Insulet Corp, Subsidiaries 35

★海外企業調査レポート[Insulet Corp (PODD)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aridis Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aridis Pharmaceuticals Inc (Aridis) is a biopharmaceutical companythat focusses on development of novel, differentiated therapies for infectious diseases. The company’s pipeline product uses disruptive platform technology to discover potent human monoclonal antibodies from patients.Its propr …
  • Perenco Holdings:企業の戦略的SWOT分析
    Perenco Holdings - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Centric Health Corporation:企業のM&A・事業提携・投資動向
    Centric Health Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Centric Health Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • LG Life Science LTD (068870)-製薬・医療分野:企業M&A・提携分析
    Summary LG Life Science LTD (LGLS) is a global life science company that offers development, production and marketing of pharmaceutical products. The company provides pipeline of antibiotic, Factive and other drug candidates. Its products include vaccines, anti-infective, chemicals, veterinary medic …
  • Linde Malaysia Sdn Bhd:企業の戦略的SWOT分析
    Linde Malaysia Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Aurora Spine Corp (ASG):企業の財務・戦略的SWOT分析
    Summary Aurora Spine Corp (Aurora) is a medical equipment provider that offers surgical tools. The company offers novel solutions in the spinal implant market through a range of minimally invasive, and regenerative spinal implant technologies. It develops and distributes spinal implant products whic …
  • Autodesk Inc:企業の戦略・SWOT・財務情報
    Autodesk Inc - Strategy, SWOT and Corporate Finance Report Summary Autodesk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Memphasys Ltd (MEM):製品パイプライン分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a bio-separations company that develops and commercializes separation techniques based on its membrane technology. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen samp …
  • Mangalore Refinery and Petrochemicals Ltd (MRPL):企業の財務・戦略的SWOT分析
    Mangalore Refinery and Petrochemicals Ltd (MRPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Cyalume Technologies Holdings, Inc.:企業の戦略・SWOT・財務情報
    Cyalume Technologies Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cyalume Technologies Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Fujikoh Company Ltd-エネルギー分野:企業M&A・提携分析
    Summary Fujikoh Company Ltd (Fujikoh Company) is a clean technology company that offers waste recycling services. The company provides biomass and environmental recycling services. It offers construction waste recycling, waste food recycling and termite dismantling and demolition services. Fujikoh C …
  • Apetit Oyj:企業の戦略・SWOT・財務情報
    Apetit Oyj - Strategy, SWOT and Corporate Finance Report Summary Apetit Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Duke Energy Ohio Inc:企業の戦略的SWOT分析
    Duke Energy Ohio Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Avillion Berhad:企業の戦略・SWOT・財務分析
    Avillion Berhad - Strategy, SWOT and Corporate Finance Report Summary Avillion Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Britannia Industries Ltd (BRITANNIA):企業の財務・戦略的SWOT分析
    Britannia Industries Ltd (BRITANNIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Kowa Co Ltd (7807):企業の財務・戦略的SWOT分析
    Kowa Co Ltd (7807) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Georgia-Pacific LLC:企業の戦略・SWOT・財務分析
    Georgia-Pacific LLC - Strategy, SWOT and Corporate Finance Report Summary Georgia-Pacific LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Zimmer Biomet Holdings Inc (ZBH)-製薬・医療分野:企業M&A・提携分析
    Summary Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company with focus on musculoskeletal healthcare. It carries out the design, development, manufacture, and marketing of reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, cr …
  • Quorum Health Corp (QHC):企業の財務・戦略的SWOT分析
    Summary Quorum Health Corp (QHC) is a healthcare service provider that offers outpatient services. The center owns and leases hospitals and outpatient centers across the US. Its hospitals provides general hospital health-care services including general acute care, emergency room, general and special …
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆